Efficacy and safety of two doses of tolterodine versus placebo in patients with detrusor overactivity and symptoms of frequency, urge incontinence, and urgency: Urodynamic evaluation

World Journal of Urology

Volumn 15, Issue 2, 1997, Pages 144-151

  Jonas, U ^a,b,c   Hofner K ^a   Madersbacher, H ^c   Holmdahl, T H ^a,b,c  

^a HANNOVER MEDICAL SCHOOL   (Germany)

^b UNIVERSITY HOSPITAL INNSBRUCK   (Austria)

^c Länssjukhuset Kvinnokliniken   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

BENZHYDRYL DERIVATIVE; CRESOL; MUSCARINIC RECEPTOR BLOCKING AGENT; PHENYLPROPANOLAMINE; PLACEBO; TOLTERODINE;

ADULT; AGED; ARTICLE; BLADDER DISEASE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG ADMINISTRATION; FEMALE; HUMAN; MALE; MIDDLE AGED; MULTICENTER STUDY; PATHOPHYSIOLOGY; RANDOMIZED CONTROLLED TRIAL; URINE INCONTINENCE; URODYNAMICS;

ADULT; AGED; AGED, 80 AND OVER; BENZHYDRYL COMPOUNDS; CRESOLS; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; MALE; MIDDLE AGED; MUSCARINIC ANTAGONISTS; PHENYLPROPANOLAMINE; PLACEBOS; URINARY BLADDER DISEASES; URINARY INCONTINENCE; URODYNAMICS;

EID: 0030630814     PISSN: 07244983     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02201987     Document Type: Article

References (8)

1. Andersson K-E (1988) Current concepts in the treatment of disorders of micturition. Drugs 35: 477-494
2. Couillard DR. Webster GD (1995) Detrusor instability. Urol Clin North Am 22: 593-612
3. Kelleher CI. et al (1994) Antichoinergic therapy: the need for continued surveillance (abstract 59). Neurol Urdoyn 13: 4
4. Lockhart JL. Shessel F. Weinstein D. Politano VA (1982) Urodynamics in women with stress and uree incontinence. Urology 20: 333-336
5. Nilvebrant L. et al (1997) Tolterodine - a new bladder selective muscarinic receptor antagonist: preclinical pharmacological and clinical data. Life Sei (in press)
6. Ouslander et al (1988) Pharmacokinetics and clinical effects of oxybutynin in geriatric patients. J Urol 140: 47-50
7. Thiiroff J. et al (1991) Randomised, double-blind, multicentrc trial on treatment of frequency, urgency and incontinence related to detrusor hyperactivity: oxybutynin versus propantheline versus placebo. J Urol 145: 813-817
8. Yarker YE, Goa KL, Fitton A (1995) Oxybutynin. A review of its pharmacodynamic and pharmacokinetic properties, and its therapeutic use in detrusor instability. Drugs Aging 6: 243-262